Impact of Robotic Cochlear Implantation on Hearing Performance in Noise
ROBOT-IC-BRUIT
2 other identifiers
interventional
140
1 country
1
Brief Summary
The purpose of this study is to compare two methods of cochlear implantation : conventional manual insertion versus robot-assisted in order to verify whether robotic insertion provides better performance in the noisy environment. To do this, we will compare the two methods of insertion of the electrode holder, on 140 patients candidates for cochlear implantation randomized in two groups (70 conventional surgery versus 70 robot-assisted surgery). All patients will be recruited during 17 months, in our Ear, nose and throat (ENT) Department of the Pitié-Salpêtrière hospital group, the first center for adult patients established in France (on average 180 patients/year). Patient will be followed for 9 months with clinical evaluation, imaging, audiometric, listening effort and quality of life assessments. These evaluations will be carried out preoperatively and postoperatively at 3 months and 6 months post-activation of the cochlear implant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2024
CompletedStudy Start
First participant enrolled
February 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFebruary 17, 2025
February 1, 2025
1.8 years
December 8, 2023
February 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Auditory performance in noise with the cochlear implant
Evolution of the intelligibility score (Variation of the percentage of words understood) for monosyllabic Lafon words presented at 60 dB SPL with a signal-to-noise ratio of 10 dB (SNR10) between the preoperative score and the score at 6 months post-implantation
At 6 months post-implantation
Secondary Outcomes (12)
Hearing performance in noise after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes
At 3 and 6 months post-implantation
Hearing performance in noise under ecological conditions after robotic cochlear implantation compared to conventional manual cochlear implantation
At 3 and 6 months post-implantation
Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for words
At 3 and 6 months post-implantation
Hearing performance in silence after robotic cochlear implantation compared to conventional manual cochlear implantation for phonemes
At 3 and 6 months post-implantation
The subjective benefit on tinnitus after robotic cochlear implantation compared to conventional manual cochlear implantation
At 3 and 6 months post-implantation
- +7 more secondary outcomes
Study Arms (2)
Experimental arm
EXPERIMENTALPatient having cochlear implantation surgery with RobOtol®.
Control arm
OTHERPatient having conventional manual cochlear implantation surgery.
Interventions
Patient having cochlear implantation surgery with RobOtol®.
Patient having conventional manual cochlear implantation surgery
Eligibility Criteria
You may qualify if:
- Adult patient ≥ 18 years old
- Patients with an indication for uni or bilateral, simultaneous or sequential cochlear implantation: severe to profound bilateral deafness with intelligibility ≤70% for Fournier dissyllabic words, in free field, at 60dB with adapted hearing aids.
- Patient able to understand the information note and give written consent
- Affiliation to a French social security system
You may not qualify if:
- Patient who does not speak French
- Etiologies of deafness known to be of bad prognosis (auditory neuropathy, congenital profound deafness, immediate post-meningitis profound deafness, vestibular schwannoma on the side of the ear to be implanted)
- Impossibility of testing the effect of the cochlear implant alone on hearing results (cochlear implantation in the context of unilateral deafness or fluctuating deafness)
- Cochlear implantation requiring the use of a perimodiolar electrode holder.
- Pregnant and breastfeeding women
- Patients wearing electronic devices, in direct connection with the brain or nervous system
- Patient included in another interventional study (Jardé 1)
- Patient under legal protection (guardianship or curatorship) or deprived of liberty
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Pitié-Salpêtrière
Paris, 75013, France
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Ghizlene LAHLOU, Dr
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2023
First Posted
February 8, 2024
Study Start
February 20, 2024
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
February 17, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor
- Access Criteria
- Researchers who provide a methodologically sound proposal.
The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients. Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.